Literature DB >> 20795820

Priming the immune system for heart disease: a perspective on group A streptococci.

Nadia M J Ellis1, David K Kurahara, Harpreet Vohra, Adita Mascaro-Blanco, Guliz Erdem, Elisabeth E Adderson, L George Veasy, Julie A Stoner, Elizabeth Tam, Harry R Hill, Karen Yamaga, Madeleine W Cunningham.   

Abstract

Although immune responses against group A streptococci and the heart have been correlated with antibodies and T cell responses against cardiac myosin, there is no unifying hypothesis about carditis caused globally by many different serotypes. Our study identified disease-specific epitopes of human cardiac myosin in the development of rheumatic carditis in humans. We found that immune responses to cardiac myosin were similar in rheumatic carditis among a small sample of worldwide populations, in which immunoglobulin G targeted human cardiac myosin epitopes in the S2 subfragment hinge region within S2 peptides containing amino acid residues 842-992 and 1164-1272. An analysis of rheumatic carditis in a Pacific Islander family confirmed the presence of potential rheumatogenic epitopes in the S2 region of human cardiac myosin. Our report suggests that cardiac myosin epitopes in rheumatic carditis target the S2 region of cardiac myosin and are similar among populations with rheumatic carditis worldwide, regardless of the infecting group A streptococcal M serotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20795820     DOI: 10.1086/656214

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Cardiac Myosin Epitopes Recognized by Autoantibody in Acute and Convalescent Rheumatic Fever.

Authors:  Alan F Garcia; Karen M Yamaga; Leigh Anne Shafer; Oana Bollt; Elizabeth K Tam; Madeleine W Cunningham; David K Kurahara
Journal:  Pediatr Infect Dis J       Date:  2016-09       Impact factor: 2.129

2.  Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.

Authors:  Safa Kalache; Rajani Dinavahi; Sean Pinney; Anita Mehrotra; Madeleine W Cunningham; Peter S Heeger
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

Review 3.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

4.  Rheumatic fever revisited.

Authors:  Madeleine W Cunningham
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 5.  Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis.

Authors:  DeLisa Fairweather; Michelle A Petri; Michael J Coronado; Leslie T Cooper
Journal:  Expert Rev Clin Immunol       Date:  2012-03       Impact factor: 4.473

Review 6.  Streptococcus and rheumatic fever.

Authors:  Madeleine W Cunningham
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

Review 7.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

8.  Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease.

Authors:  Davina Gorton; Suchandan Sikder; Natasha L Williams; Lisa Chilton; Catherine M Rush; Brenda L Govan; Madeleine W Cunningham; Natkunam Ketheesan
Journal:  Autoimmunity       Date:  2016-08-25       Impact factor: 2.815

Review 9.  Revisiting the pathogenesis of rheumatic fever and carditis.

Authors:  Rajendra Tandon; Meenakshi Sharma; Y Chandrashekhar; Malak Kotb; Magdi H Yacoub; Jagat Narula
Journal:  Nat Rev Cardiol       Date:  2013-01-15       Impact factor: 32.419

Review 10.  Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection.

Authors:  Madeleine W Cunningham
Journal:  Int Rev Immunol       Date:  2014-06-03       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.